Sarcopenia is the progressive loss of skeletal muscle mass, strength, and function that comes with aging. The word combines the Greek roots for "flesh" (sarx) and "loss" (penia). It is not a disease you catch; it is a slow drift that begins for most adults somewhere in their thirties and accelerates after the age of fifty.
On its own, losing a little muscle sounds harmless. The problem is what muscle does. Muscle is the engine for every functional task of daily life — rising from a chair, climbing stairs, carrying groceries, catching yourself when you stumble. It is also a metabolically active organ that helps regulate blood sugar and stores reserves the body draws on during illness. When muscle quietly erodes for decades, the first noticeable sign is often a fall, a struggle with stairs, or a sudden loss of independence that seems to come out of nowhere.
How fast does it happen?
Research summarized by aging and muscle scientists suggests that adults can lose roughly 3–8% of their muscle mass per decade after age thirty, with the rate of loss increasing after sixty. Strength can decline even faster than mass — meaning a person may lose the ability to produce force more quickly than they lose the muscle itself. This is why two people of the same size can have very different functional capacity.
Why it matters as a public-health issue
Canada is now what demographers call a "super-aged" society, with more than one in five people aged 65 or older. As the population ages, the number of adults living with low muscle mass and low strength rises with it. Clinical consensus groups such as the European Working Group on Sarcopenia in Older People (EWGSOP2) have published criteria to help health professionals identify the condition, but awareness among the general public remains low.
The most important thing to understand is that sarcopenia is not an inevitable part of aging to be passively accepted. The trajectory can be slowed and, in many cases, reversed. The single most effective lever is not a supplement or a medication — it is structured, progressive resistance training, which we cover in a companion summary.
References
- Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age and Ageing, 2019.
- Statistics Canada. Canada's population estimates: age and sex.
- Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Current Opinion in Clinical Nutrition and Metabolic Care, 2004.
Last updated June 1, 2026.